Barclays Has Lowered Expectations for Integral Ad Science (NASDAQ:IAS) Stock Price

Integral Ad Science (NASDAQ:IAS - Get Free Report) had its target price cut by equities researchers at Barclays from $14.00 to $7.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an "equal weight" rating on the stock. Barclays's price objective would suggest a potential downside of 1.96% from the stock's previous close.

Several other research analysts have also recently weighed in on IAS. Baird R W cut Integral Ad Science from a "strong-buy" rating to a "hold" rating in a research report on Friday, March 28th. Benchmark reaffirmed a "hold" rating on shares of Integral Ad Science in a report on Friday, February 28th. Robert W. Baird restated a "neutral" rating and issued a $9.00 price objective (down previously from $16.00) on shares of Integral Ad Science in a research note on Friday, March 28th. Oppenheimer reiterated an "outperform" rating on shares of Integral Ad Science in a research note on Friday, February 28th. Finally, Truist Financial increased their price target on Integral Ad Science from $16.00 to $17.00 and gave the company a "buy" rating in a research note on Monday, March 3rd. Six research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, Integral Ad Science currently has a consensus rating of "Moderate Buy" and an average price target of $13.68.

Integral Ad Science Trading Up 3.8 %

IAS traded up $0.26 during mid-day trading on Monday, hitting $7.14. The stock had a trading volume of 756,991 shares, compared to its average volume of 1,100,768. The stock's fifty day simple moving average is $8.45 and its 200-day simple moving average is $9.97. The firm has a market capitalization of $1.17 billion, a price-to-earnings ratio of 35.70, a price-to-earnings-growth ratio of 1.06 and a beta of 1.53. Integral Ad Science has a 1-year low of $6.26 and a 1-year high of $13.62. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.71 and a quick ratio of 3.71.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its quarterly earnings data on Friday, February 28th. The company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.03). Integral Ad Science had a return on equity of 3.47% and a net margin of 6.39%. The business had revenue of $153.00 million for the quarter, compared to analyst estimates of $148.83 million. During the same period in the previous year, the business posted $0.06 EPS. The business's quarterly revenue was up 13.9% compared to the same quarter last year. As a group, research analysts forecast that Integral Ad Science will post 0.26 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Lisa Utzschneider sold 8,547 shares of the firm's stock in a transaction dated Monday, April 7th. The stock was sold at an average price of $6.85, for a total value of $58,546.95. Following the sale, the chief executive officer now directly owns 341,271 shares of the company's stock, valued at $2,337,706.35. This trade represents a 2.44 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Insiders have sold 90,303 shares of company stock worth $706,660 over the last ninety days. Corporate insiders own 2.00% of the company's stock.

Institutional Investors Weigh In On Integral Ad Science

Hedge funds have recently made changes to their positions in the stock. Barclays PLC boosted its position in Integral Ad Science by 207.1% in the third quarter. Barclays PLC now owns 127,733 shares of the company's stock valued at $1,380,000 after buying an additional 86,133 shares in the last quarter. Geode Capital Management LLC grew its position in Integral Ad Science by 6.4% during the 3rd quarter. Geode Capital Management LLC now owns 1,834,659 shares of the company's stock worth $19,836,000 after acquiring an additional 110,149 shares during the last quarter. Franklin Resources Inc. increased its holdings in Integral Ad Science by 12.9% in the 3rd quarter. Franklin Resources Inc. now owns 110,449 shares of the company's stock worth $1,191,000 after purchasing an additional 12,647 shares in the last quarter. JPMorgan Chase & Co. raised its position in Integral Ad Science by 47.6% in the third quarter. JPMorgan Chase & Co. now owns 717,528 shares of the company's stock valued at $7,756,000 after purchasing an additional 231,271 shares during the last quarter. Finally, Jennison Associates LLC grew its holdings in shares of Integral Ad Science by 3.3% during the fourth quarter. Jennison Associates LLC now owns 63,538 shares of the company's stock worth $663,000 after purchasing an additional 2,046 shares during the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.